Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ProPhase Labs (PRPH) Equity Average (2016 - 2025)

Historic Equity Average for ProPhase Labs (PRPH) over the last 15 years, with Q3 2025 value amounting to $9.1 million.

  • ProPhase Labs' Equity Average fell 7774.14% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.1 million, marking a year-over-year decrease of 7774.14%. This contributed to the annual value of $28.4 million for FY2024, which is 4979.74% down from last year.
  • Latest data reveals that ProPhase Labs reported Equity Average of $9.1 million as of Q3 2025, which was down 7774.14% from $13.3 million recorded in Q2 2025.
  • ProPhase Labs' 5-year Equity Average high stood at $68.0 million for Q3 2022, and its period low was $9.1 million during Q3 2025.
  • In the last 5 years, ProPhase Labs' Equity Average had a median value of $50.2 million in 2021 and averaged $45.7 million.
  • Per our database at Business Quant, ProPhase Labs' Equity Average surged by 40144.02% in 2021 and then tumbled by 7774.14% in 2025.
  • Quarter analysis of 5 years shows ProPhase Labs' Equity Average stood at $53.4 million in 2021, then rose by 23.07% to $65.8 million in 2022, then decreased by 19.57% to $52.9 million in 2023, then plummeted by 57.02% to $22.7 million in 2024, then tumbled by 59.77% to $9.1 million in 2025.
  • Its last three reported values are $9.1 million in Q3 2025, $13.3 million for Q2 2025, and $11.2 million during Q1 2025.